budesonide
Budesonide is nebulized for maintenance and prophylactic treatment of asthma including patients who require oral corticosteroids and those who may benefit from a systemic dose reduction. It was initially patented in 1973. It sold under the brand name Pulmicort among others, is a medication of the corticosteroid type.. Reference standards of Budesonide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-Hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoacetic Acid
Catalogue No.:PA 02 54720
CAS :
NA
Molecular Formula : C25H32O7
Molecular Weight : 444.52
